The Pharmacy Council of Nigeria (PCN) and Sproxil have officially entered into a transformative Memorandum of Collaboration aimed at integrating agentic AI systems into the nation’s burgeoning e-pharmacy landscape. This strategic agreement, formalised on 29 September 2026, marks a pivotal shift in how regulatory bodies and technology innovators intersect to manage the digital evolution of pharmaceutical services in Africa’s most populous nation. The signing ceremony took place in Kigali, Rwanda, during the high-profile Investing in Innovation Africa (i3) Access to Markets event, which was convened alongside the Africa HealthTech Summit.
Contextualizing the Regulatory Environment
The collaboration arrives at a critical juncture for Nigeria’s healthcare sector. With the recent enactment of the Electronic Pharmacy Regulations 2026, the federal government has established a comprehensive national framework designed to govern digital pharmacy operations. These regulations serve as a bedrock for standardizing virtual pharmacy services, addressing long-standing concerns regarding patient data protection, the integrity of the drug supply chain, and the maintenance of professional standards in an increasingly borderless digital marketplace.
By partnering with Sproxil—a company with over 15 years of experience in deploying supply chain intelligence and verification technologies—the PCN is signaling its intent to move beyond passive regulation. The adoption of "agentic AI"—systems capable of making autonomous decisions based on pre-defined professional guidelines—is intended to assist pharmacists in real-time, ensuring that digital interactions do not compromise the standard of care traditionally associated with brick-and-mortar pharmacies.
Chronology of the Strategic Partnership
The genesis of this collaboration can be traced back to the growing necessity for a structured approach to health-tech integration.
- 2022: The Pharmacy Council of Nigeria Act 2022 was signed into law, granting the PCN expanded statutory authority to regulate all aspects of pharmacy education and practice, including the emerging digital domain.
- Early 2026: Drafting and subsequent implementation of the Electronic Pharmacy Regulations 2026 provided the legal foundation for e-pharmacy operations.
- September 2026: The Investing in Innovation Africa (i3) event in Kigali served as the global stage for the formal signing of the Memorandum of Collaboration.
- Late 2026 and Beyond: The partnership moves into the implementation phase, where jointly approved pilot programs will be introduced to test the efficacy of agentic AI in live pharmacy environments.
The Role of Agentic AI in Pharmaceutical Care
Unlike traditional decision-support systems that merely present data for human interpretation, agentic AI acts as a sophisticated digital assistant. Within the context of the PCN’s new framework, these systems are designed to monitor for contraindications, flag potential counterfeit medications, and ensure that every digital prescription follows the strict protocols established by the Council.
The core philosophy of this collaboration is that technology should remain a tool that empowers, rather than replaces, the professional judgment of the pharmacist. By delegating routine verification and diagnostic checks to AI agents, pharmacists are freed to focus on higher-level patient counseling, medication therapy management, and complex clinical interventions.
Bridging the Gap: Data, Trust, and Supply Chain Integrity
The pharmaceutical sector in Africa has historically faced significant challenges, including the prevalence of substandard and falsified (SF) medicines. Sproxil’s long-standing track record in this space provides the PCN with a robust technological partner. By leveraging real-world data, the AI systems are expected to improve the visibility of the supply chain.
When a consumer interacts with an e-pharmacy, the agentic AI can verify the authenticity of the product against a secure database in milliseconds. If a discrepancy is detected, the system can trigger an immediate alert, effectively preventing the distribution of illicit drugs. This approach does more than just ensure safety; it fosters consumer trust—a fundamental requirement for the growth of digital health services in Nigeria.
Official Perspectives and Institutional Commitment
While the agreement is in its infancy, the presence of leadership from both organizations at the signing ceremony in Kigali underscores the seriousness of the commitment. The delegation, which included Dr. Ashifi Gogo, Founder and CEO of Sproxil, and Amina Omar Shekarau, Director of Inspection, Monitoring and Quality Assurance at the PCN, emphasized the necessity of a collaborative approach.
For the PCN, the partnership is a way to ensure that the "Electronic Pharmacy Regulations" are not just administrative documents but are instead supported by the best available technology. For Sproxil, the opportunity to work directly with a federal regulatory body allows for the scaling of its technology within a protected and highly regulated environment, setting a precedent for other African nations to follow.
Analysis of Broader Implications
The implications of this partnership extend far beyond the immediate technological integration.
- Regulatory Harmonization: By working with a private tech firm to implement specific AI protocols, the PCN is demonstrating a model of "agile regulation." This allows the government to adapt to technological changes faster than traditional legislative processes might otherwise allow.
- Economic Impact on E-Pharmacies: The clear guidelines and the support of AI-driven compliance tools will likely lower the barrier to entry for legitimate digital pharmacies while making it significantly harder for unauthorized or illegal entities to operate. This will foster a healthier competitive environment.
- Standardization of Care: In a country where pharmacy practice can vary significantly between urban and rural centers, digital tools that enforce national standards provide a layer of equity. A patient in a remote village accessing a licensed e-pharmacy should, theoretically, receive the same level of safety and verification as a patient in a major city like Lagos or Abuja.
- Data-Driven Policy Making: The data generated through these AI systems will be invaluable to the PCN. By analyzing patterns in prescription queries, drug demand, and supply chain disruptions, the Council can make more informed, data-driven decisions regarding pharmaceutical policy and public health interventions.
Addressing Potential Challenges
Despite the optimism surrounding this partnership, the integration of AI into healthcare is not without its challenges. Data privacy remains a paramount concern. The PCN has emphasized that all AI applications must operate within the strict boundaries of Nigeria’s data protection laws. Furthermore, there is the issue of digital infrastructure; for these systems to be effective, they require reliable internet access and stable electricity—two areas that continue to see improvement but remain inconsistent across parts of the country.
Additionally, the "human-in-the-loop" requirement is a critical component of the agreement. The PCN is unlikely to cede ultimate accountability to an algorithm. Therefore, the training of pharmacists to effectively utilize these AI tools will be a key performance indicator for the success of the collaboration in the coming months.
Future Outlook and Continued Development
As the collaboration progresses, stakeholders can expect the introduction of pilot programs aimed at testing the interoperability of Sproxil’s technology with existing hospital and pharmacy management systems. These pilots will be closely monitored by the PCN to ensure that the results align with public health objectives.
The partnership also leaves the door open for future expansions. As the technology matures, it could potentially evolve to include predictive analytics for drug shortages, automated reporting of adverse drug reactions, and real-time integration with national health insurance schemes to streamline claims processing.
In summary, the alliance between the Pharmacy Council of Nigeria and Sproxil represents a sophisticated, forward-thinking approach to the modernization of healthcare. By prioritizing the responsible use of agentic AI, the PCN is positioning Nigeria as a leader in the digital pharmaceutical space in Africa, ensuring that as the industry moves online, the core tenets of the profession—safety, verification, and patient-centered care—remain uncompromised. As the regulatory framework matures and the technology is refined, this partnership will likely serve as a blueprint for the intersection of government oversight and private-sector innovation for years to come.
